Everspin (MRAM) Form 3 EVERSPIN / David Schrenk ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Schrenk David

(Last) (First) (Middle)

C/O EVERSPIN TECHNOLOGIES, INC.

5670 W. CHANDLER BOULEVARD, SUITE 130

(Street)

CHANDLER AZ 85226

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/28/2023

3. Issuer Name and Ticker or Trading Symbol
EVERSPIN TECHNOLOGIES INC [ MRAM ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
VP Sales and Business

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	24,609(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	08/19/2028	Common Stock	2,110	8.52	D
Stock Option (Right to Buy)	(3)	08/25/2029	Common Stock	3,057	6.86	D
Stock Option (Right to Buy)	(4)	03/23/2030	Common Stock	7,292	2.23	D
Stock Option (Right to Buy)	(5)	04/06/2030	Common Stock	1,209	2.56	D
Stock Option (Right to Buy)	(6)	08/05/2031	Common Stock	12,500	5.62	D
Stock Option (Right to Buy)	(7)	03/13/2032	Common Stock	15,000	8.17	D

Explanation of Responses:

1. Includes 22,043 shares subject to unvested restricted stock units.

2. Fully vested.

3. The option vested as to 25% of the shares on August 26, 2020, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on August 26, 2023. The original grant was for 6,986 shares, of which 3,929 shares have been exercised.

4. The option vested as to 25% of the shares on March 24, 2021, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on March 24, 2024. The original grant was for 12,500 shares, of which 5,208 shares have been exercised.

5. The option vested as to 25% of the shares on April 7, 2021, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on April 7, 2024. The original grant was for 2,000 shares, of which 791 shares have been exercised.

6. The option vested as to 25% of the shares on March 10, 2022, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on March 10, 2025.

7. The option vested as to 25% of the shares on February 28, 2023, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on February 28, 2026.

Remarks:

	/s/ Anthony Griff, Attorney-in-Fact	03/07/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.